Bad Blood: Secrets and Lies in a Silicon Valley Startup

John Carreyrou, the Wall Street Journal reporter who broke the Theranos story, turned his investigation into one of the most acclaimed nonfiction books of the decade. Bad Blood chronicles the rise and fall of Elizabeth Holmes and her blood-testing startup Theranos, which claimed to have developed technology that could run hundreds of medical tests from a single drop of blood. The technology didn’t work. The company knew it didn’t work. And people’s health was put at risk as a result.

The book reads less like business journalism and more like a psychological thriller, and that quality has made it a crossover hit with readers who would never normally pick up a business book. The narrative is propulsive, the characters are vivid, and the scale of the deception, abetted by a board of directors that included Henry Kissinger and George Shultz, is staggering.

The Anatomy of a Fraud

Carreyrou’s reporting is the book’s foundation, and it’s extraordinary. He reconstructed the inner workings of Theranos through interviews with over 150 people, many of whom risked legal retaliation to speak. The level of detail, from specific meetings to internal emails to the technical specifications of failed prototypes, creates a narrative that feels both comprehensive and authoritative.

The portrait of Elizabeth Holmes is fascinating without being sympathetic. Carreyrou shows how Holmes’s charisma, her deep voice (reportedly affected), her black turtleneck uniform (modeled on Steve Jobs), and her ability to recruit powerful believers created a reality distortion field that kept the fraud running for over a decade. He doesn’t psychoanalyze her but lets the facts speak.

Sunny Balwani, Holmes’s partner and Theranos COO, provides the book’s most chilling dimension. His management through intimidation, his surveillance of employees, and his volatile temper created a culture of fear that prevented internal dissent from reaching the outside world. The sections detailing Balwani’s behavior are deeply disturbing.

The whistleblowers are the book’s heroes, and Carreyrou gives them their due. Tyler Shultz, Erika Cheung, and others who risked their careers and faced legal threats to expose the fraud are portrayed with the admiration they deserve. Their stories add a human dimension that elevates the narrative beyond business reporting.

The Structure of Inevitability

The book’s chronological structure, while clear and effective, means that readers who followed the news coverage know where the story ends. This reduces the suspense for informed readers, though Carreyrou’s granular reporting provides enough new detail to maintain engagement.

Some readers feel that the book could explore more deeply why so many powerful, intelligent people believed Holmes. The board of directors’ credulity is documented but not fully analyzed. The broader cultural conditions, Silicon Valley’s worship of youth, disruption, and “vision,” that enabled the fraud receive less attention than the fraud itself.

The technical details about blood testing, while necessary for understanding the fraud’s scope, can slow the narrative in places. Readers without scientific background may find certain passages dense, though Carreyrou generally explains the science accessibly.

The book focuses almost exclusively on the fraud and its mechanics, with less attention to the broader healthcare implications. The patients who received inaccurate test results, whose stories are briefly mentioned, could have provided a more visceral demonstration of the human cost.

Silicon Valley’s Mirror

Bad Blood works as both a specific story and a broader indictment of a culture. The Theranos fraud was enabled by the same dynamics that power legitimate Silicon Valley success: visionary founders, dazzled investors, media hype, and the belief that technology can solve any problem. Carreyrou doesn’t generalize excessively, but the implications are clear: the line between bold innovation and dangerous fraud can be frighteningly thin when no one asks hard questions.

The book also demonstrates the essential role of investigative journalism. Carreyrou’s reporting, which Holmes and Theranos’s army of lawyers tried desperately to suppress, is the reason the fraud was exposed. In an era when journalism is under constant pressure, Bad Blood is a reminder of what the profession can accomplish.

Should You Read Bad Blood?

If you’re interested in how fraud works, how power corrupts, or how Silicon Valley’s mythology can shield dangerous behavior, this is essential reading. The narrative is compelling enough to appeal to readers who don’t normally read business books, and the reporting is thorough enough to satisfy those who do. If you already know the Theranos story in detail, the book provides depth that news coverage couldn’t, but the basic trajectory will be familiar.

The Verdict on Bad Blood

Bad Blood is investigative journalism operating at the highest level, transformed into a narrative that is as gripping as any thriller. Carreyrou’s reporting is meticulous, his storytelling is sharp, and the story itself, a young woman deceiving the most powerful people in America with technology that didn’t work, is almost too extraordinary to believe. The chronological structure and limited analysis of enabling culture are minor limitations in a book that accomplishes its primary mission brilliantly: telling the truth about a company that was built on lies.